Sandoz Group AG (SWX:SDZ)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
63.42
-0.52 (-0.81%)
At close: Mar 10, 2026
Market Cap27.67B +53.1%
Revenue (ttm)8.85B +7.4%
Net Income724.76M
EPS1.66
Shares Out432.69M
PE Ratio38.58
Forward PE20.36
Dividend0.80 (1.25%)
Ex-Dividend DateApr 13, 2026
Volume1,019,736
Average Volume896,029
Open65.20
Previous Close63.94
Day's Range63.42 - 65.22
52-Week Range26.25 - 72.70
Beta0.33
RSI46.97
Earnings DateFeb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 22,356
Stock Exchange SIX Swiss Exchange
Ticker Symbol SDZ
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements